Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Tyme Technologies, Inc. - Common Stock (NQ:TYME)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 16, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tyme Technologies, Inc. - Common Stock

< Previous 1 2 3 Next >
44 Stocks Moving In Tuesday's Mid-Day Session
Gainers Oragenics, Inc. (NASDAQ: OGEN) surged 55.9% to $0.9749 after the company announced it entered into a licensing agreement with the National Research Council of Canada that... 
Via Benzinga
34 Stocks Moving in Tuesday's Pre-Market Session
Gainers Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) shares rose 139.7% to $7.48 in pre-market trading after the company announced it entered a non-binding letter of intent to... 
Via Benzinga
Earnings Scheduled For August 10, 2021
Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:... 
Via Benzinga
TYME Technologies, Inc. to Host Conference Call and Webcast on Tuesday, August 10th at 8:30 AM ET
From TYME Technologies, Inc.
Via Business Wire
21 Stocks Moving in Monday's Pre-Market Session
Gainers Exicure, Inc. (NASDAQ: XCUR) shares rose 41.5% to $1.91 in pre-market trading. Ipsen and Exicure signed an exclusive collaboration agreement to research, develop, and... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Infinity Pharmaceuticals (NASDAQ:INFI) shares moved upwards by 45.98% to $2.22 during Wednesday's regular session. As of 12:30 EST, this security is trading at... 
Via Benzinga
74 Biggest Movers From Yesterday
Gainers Bit Digital, Inc. (NASDAQ: BTBT) shares jumped 109.7% to close at $8.87 on Monday after the company announced it entered into a second strategic co-mining agreement with... 
Via Benzinga
Mid-Afternoon Market Update: Dow Rises 50 Points; Iterum Therapeutics Shares Slide
Toward the end of trading Monday, the Dow traded up 0.15% to 35,112.39 while the NASDAQ fell 0.10% to 14,822.88. The S&P also rose, gaining 0.09% to 4,415.85. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
Tyme Technologies Stock Rallies: A Technical Analysis
Shares of Tyme Technologies, Inc. (NASDAQ: TYME) may have just crashed into a wall of sellers. This means the rally may be over. Resistance is a large group of sellers looking to... 
Via Benzinga
TYME Stock: The Cancer Treatment News That’s Boosting Tyme Today
TYME stock is making big moves today after it received patent approval for its cancer treatment. Now, it will move into deeper development. 
Via InvestorPlace
Topics Intellectual Property
Exposures Intellectual Property
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Tyme Technologies (NASDAQ:TYME) shares rose 77.31% to $1.92 during Monday's regular session. Tyme Technologies's stock is trading at a volume of 215.0... 
Via Benzinga
Mid-Day Market Update: Crude Oil Down 1%; Xenetic Biosciences Shares Spike Higher
Midway through trading Monday, the Dow traded down 0.19% to 34,996.16 while the NASDAQ fell 0.07% to 14,827.27. The S&P also fell, dropping 0.08% to 4,408.04. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
48 Stocks Moving In Monday's Mid-Day Session
Gainers Bit Digital, Inc. (NASDAQ: BTBT) gained 38% to $5.83 after the company announced it entered into a second strategic co-mining agreement with Digihost Technology Inc. The... 
Via Benzinga
What You Need To Know Before Buying TYME Technologies Inc (NASDAQ: TYME) Stock
TYME Technologies is a new biotechnology company that develops “cancer metabolism-based therapies” or CMBTs. These treatments are designed to work across a wide range... 
Via Benzinga
Tyme Granted U.S. Patent Claims Covering Use of Tyrosine-Based Drug Delivery Method to Treat Cancer
From Tyme Technologies, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Alterity Therapeutics (NASDAQ:ATHE 
Via Benzinga
64 Biggest Movers From Friday
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
46 Stocks Moving In Friday's Mid-Day Session
Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Tyme Stock Is Trading Higher On Pipeline Update After Strategic Review, Q4 Earnings
Tyme Technologies Inc (NASDAQ: TYME) announced a breast cancer trial with Georgetown University named OASIS. Enrollment is expected to start in Q3 of 2021. The... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Tyme Technologies (NASDAQ:TYME) s... 
Via Benzinga
Tyme Technologies, Inc. Completes Strategic Review, Announces OASIS Breast Trial With Georgetown University, and Reports Fiscal Year 2021 Financial Results
From Tyme Technologies, Inc.
Via Business Wire
Earnings Scheduled For June 10, 2021
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is expected to report quarterly loss at $0.20 per share on revenue of $11.30 million. • Alithya... 
Via Benzinga
TYME Technologies, Inc. to Host Conference Call and Live Video Webcast on Thursday, June 10th at 5:00 PM ET
From TYME Technologies, Inc.
Via Business Wire
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-... 
Via Benzinga
Exposures Product Safety
2 Meme Stocks Test Resistance For A Larger Move
Express and Tyme fell into long periods of consolidation after soaring 1,078% and 202%, respectively. 
Via Talk Markets
2 Meme Stocks Test Resistance For A Larger Move
Express Inc (NYSE:EXPR) and Tyme Technologies Inc 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Evaxion Biotech (NASDAQ:EVAX) sha... 
Via Benzinga
TYME Appoints Frank L. Porfido as Chief Financial Officer
From TYME Technologies, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers BioVie (NASDAQ:BIVI) shares rose 11.62% to $24.0 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 27.3K shares,... 
Via Benzinga
Insider Sells Tyme Technologies Shares
Tyme Technologies Inc (NASDAQ:TYME) was trading 1.2% lower from the previous closing price. Demurjian Michael filed a Form 4 with the SEC on Wednesday, April 7. The insider... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.